Background: A documented penicillin allergy is associated with increased morbidity
penicillin allergy have no subsequent reactions to penicillin or betalactam antibiotics (BLAs). 5 It is thought that up to 90% of these patients have an unnecessary label of "penicillin allergy". 5 This is partly due to overuse of the term "allergy" when confounding symptoms related to the patient's illness may be attributed to penicillin "allergy". 1 However, such patients commonly receive second-line broad-spectrum antibiotics for infections that may be treated with first-line BLAs. 11 Common antibiotics that substitute first-line penicillins include fluoroquinolones, clindamycin, vancomycin, and thirdgeneration cephalosporins. For this reason, a documented penicillin allergy increases patient risk for infections caused by Clostridium difficile, methicillin-resistant Staphylococcus aureus (MRSA), and vancomycin-resistant enterococcus (VRE). 6 Furthermore, a documented penicillin allergy may be associated with a prolonged hospital stay related to longer duration of treatment and adverse effects related to second-line antibiotic use. 6 This may have implications on healthcare utilization and cost.
A significant number of hospitalized patients are treated with antibiotics. 12 Hospitalization offers an opportunity to address and rule out a penicillin allergy especially as adverse outcomes related to a penicillin allergy are common during a hospitalization event. Penicillin skin testing (PST) is a validated tool to test for IgE-mediated penicillin hypersensitivity. Drug challenge is, however, the gold standard to rule out any form of drug hypersensitivity. 2 PST has a very high negative predictive value when both major and minor determinants are used. 2, 13 BLAs can thus be safely administered following a negative PST. 14, 15 Despite some initial concerns that an inpatient PST may not be valid due to interfering inpatient factors, PST for major and minor determinants was negative in 78% of 726 hospitalized patients with a history of penicillin allergy. 16 This value was comparable to other prior studies. 17, 18 However, there has been a steady decline in the proportion of PSTs since 1995 that has been independent of study subject's age and time since reported penicillin reaction. 12 Data over the past 20 years have consistently shown the proportion of negative PSTs to be between 95% and 99% in outpatient, perioperative, and inpatient settings. 19 However, studies of inpatient populations have had small cohorts when compared to Sogn et al., 1992 , calling for an updated negative PST in a larger inpatient population. 16 The Infectious Diseases Society of America and Society for Healthcare Epidemiology of America guidelines for implementing an antibiotic stewardship program determined that penicillin skin testing to assess penicillin allergy merits a weak recommendation. 20 However, there is substantial morbidity related to unconfirmed penicillin allergy. 21 Multiple studies have consistently shown inpatient PST to decrease use of broad-spectrum antibiotics and decrease cost. 11, 22, 23 However, inpatient PST (with or without oral amoxicillin challenge) is not often readily available with only around 60% of institutions having PST available. 24 Other inpatient interventions to address a penicillin allergy may include pharmacy-led initiatives or guideline-driven protocols with administration of penicillin test doses in patients deemed to be low risk for anaphylaxis. 10, 25 In such cases, patient risk is stratified based on history and nature of the prior presumed penicillin allergy. Concerns for such an approach are that patients with a vague history of penicillin allergy may have a positive PST. 26 It is as yet unclear whether inpatient interventions addressing a penicillin allergy have any implications on clinical outcomes other than antibiotic utilization and cost. Any inpatient intervention that would impact patient morbidity (such as length of hospitalization, discharge on intravenous antibiotics, and readmission rate) may increase rates of inpatient allergy testing and make a case for improving inpatient infrastructure for penicillin allergy testing. This systematic review and meta-analysis was designed to address the following aims:
• To outline major inpatient interventions that address a penicillin allergy during an index admission when a patient would require a penicillin antibiotic.
• To ascertain the validity of inpatient penicillin skin testing to safely rule out a penicillin allergy.
• To identify clinically relevant outcomes following inpatient penicillin allergy testing. 
| Types of interventions
We included and evaluated studies that implemented any intervention to rule out a penicillin allergy whether it was a consult servicedriven process, guideline-driven protocol, or standard (PST) for major and minor determinants with or without oral penicillin challenge.
| Types of outcome measures
We included all outcomes described including the following: adverse outcomes related to the inpatient intervention, proportion of patients testing negative for PCN allergy, change in management including antimicrobial administration, adverse outcomes related to change in management following testing, effect on cost, and other longitudinal healthcare outcomes. We recorded the study design, sample size, sampling methods, type of inpatient population, inpatient intervention addressing penicillin allergy, and subsequent clinical outcomes described. We contacted the study authors to obtain additional information if it was not available from the published reports or reports from the studies. We conducted a qualitative analysis of the study cohort and inpatient intervention to address PCN allergy and assessed the clinical outcomes described.
| Search methods
We assessed the risk of bias in included studies using the Newcastle-Ottawa Quality Assessment Scale for cohort studies and casecontrol studies (Table S2 and S3) . 27 We performed populationweighted analysis on all comparable observational cohort studies reporting the rate of negative PSTs to assess whether it would be a reproducible test when compared to outpatient data. We calculated the 95% confidence interval for population-weighted means using the Wilson score interval. 28 We performed population-weighted analysis on cohort studies reporting a common clinical outcome after implementation of the same or consistently similar inpatient penicillin allergy test.
| RESULTS
Our search strategy identified 1836 unique bibliographic citations of which 74 were selected for full-text evaluation ( Figure 1 ). We identified 24 studies, 17 full-text articles, and seven conference abstracts. Two studies were case-cohort studies, while the other 22 studies were cohort studies. 10, 11, 15, 22, 23, 25, [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] The included studies were grouped according to their inpatient population, inpatient intervention, and clinical outcomes described ( Figure 2 ). and quinolone use following an inpatient guideline to rule out penicillin allergy. 32 The study was omitted from pooled-cohort analysis as the primary outcome was to assess increase in BLA test doses rather than individual patient or population-based clinical outcomes.
Specific studies described specific infection groups such as infective endocarditis 45 and MSSA bacteremia. 33 The commonest inpatient intervention performed was penicillin skin prick or intradermal testing with or without subsequent challenge of oral penicillin (or its derivative). This was the primary intervention in 19 studies (Table S1 , Figure 2 ). The proportion of negative PSTs ranged between 79% and 100%. Motosue et al.
reported a negative PST in 79% of inpatients with 20% of tests being indeterminate. 40 Given that the study was a retrospective review, patients with indeterminate tests could not be retested. The population-weighted mean for a negative PST was 95.1% [CI 93.8-
96.1] (Figure 3
. One study implemented an inpatient allergy consult prior to PST. 43 Sigona et al., 2016, reported a pharmacy-driven patient interview that showed 65.6% of patients were subsequently switched to BLAs. 25 The most commonly reported clinical outcome was a change in antimicrobial therapy (20 studies). Studies consistently reported change to a narrower spectrum antibiotic, switching to BLAs, and subsequently increased prescription of penicillin and cephalosporins. Two studies reported an annual healthcare saving, 22,37 three studies found a cost saving per individual patient, 11, 23, 42 while two studies were unable to report a statistically significant cost benefit 31, 35 (Table S1 , Figure 2 ).
Very few adverse events related to testing were reported. These were individual cases of anaphylaxis that were more common with oral amoxicillin challenge at an incidence of less than 1 percent. 19 However, it must be reiterated that a PST in isolation does not rule out the spectrum of immunologically mediated hypersensitivities that encompass drug allergy. PST was traditionally reserved for patients with no alternative other than penicillin for their infection. However, PST has emerged to play a pivotal role in antibiotic stewardship to avoid unnecessary use of broad-spectrum antibiotics that may be less effective, more toxic, more expensive; require lengthier intravenous administration; and are associated with prolonged hospital stay. 5, 6 For the aforementioned reasons, a history of presumed penicillin allergy is not as benign as previously thought.
Identifying changes in antibiotic prescription is an easily measurable outcome that is suggestive of decreased adverse effects However, it highlights a gross missed opportunity for subsequent healthcare encounters and may overestimate the benefit of changes in antibiotics during the index admission.
A substantial change was noted in prescribing narrower spectrum antibiotics following PST (Figure 3) . A rise in both penicillin and cephalosporin antibiotics was seen, possibly owing to the concern for cross-reactivity with cephalosporins in a history of penicillin allergy. 49 Conversely, a decrease in vancomycin and fluoroquinolone use was reported in all studies assessing this change. This suggests a possible relative risk reduction in acquiring health care-related infection such as VRE and C. difficile, albeit such outcomes were not measured directly possibly owing to small patient cohorts. A greater change in antibiotic prescribing practices was noted in the ICU setting as compared to the general inpatient population following penicillin testing (Figure 4 ). This occurred despite comparable negative PSTs in both cohorts. Such findings may be related to ICU physician-related awareness and need to rule out penicillin allergy when dealing with complex patients likely having multi-organ dysfunction. Furthermore, the growing problem of antibiotic resistance in the ICU is associated with greater mortality, morbidity, and healthcare cost. 50 While PST is a valid and sensitive test to rule out an immediate hypersensitivity to penicillin, it is worth noting to a drug challenge remains the gold standard to rule out a drug hypersensitivity reaction. 1 Further, European populations have a lower rate of reactivity to the major determinant penicilloyl-polylysine in a standard PST. This is likely due to the higher prevalence of amoxicillin/ampicillin allergy particularly in Southern Europe with patients being sensitized to the R-group side chain. Populations in the United States are more likely to develop hypersensitivity to the beta-lactam core. 51 As a result, adverse events may occur at a higher rate in European populations if only PST is used. Owing to such geographical differences in sensitization profiles, a standard evaluation for penicillin allergy should include a PST followed by graded drug challenge when appropriate. 52, 53 This would also follow consensus guidelines on evaluating drug allergy as one may miss immunologically mediated hypersensitivities other than IgE-mediated reactions using PST alone.
1
A longitudinal follow-up with age-and sex-matched controls would be helpful to delineate specific clinical outcomes following PST that may be related to use of broad-spectrum antibiotics. Longitudinal follow-up would also help quantify (and possibly magnify) the effect of cost. Antibiotic therapy is more costly in patients hospitalized with true penicillin allergy. This is partly due to higher cost per dose of alternative antibiotic and longer duration of treatment. 56 Forrest et al. reported no effect on cost probably owing to the cost benefit solely being calculated at the index admission. 35 However, estimates of annual cost savings are significant and may be more so considering decreased healthcare utilization related to lower risk of health care-related infection and decreased hospital stay. 22, 37 This systematic review and meta-analysis has a number of limitations that are largely related to the quality of studies identified. The level of evidence for such findings was obtained from one case-control study 39 and observational cohort studies. reaffirms that penicillin skin testing should be strongly recommended as an initial evaluation of penicillin allergy. This recommendation should be reflected in clinical guidelines addressing drug allergy and antibiotic stewardship. 1, 20, 21, 53 It would be difficult to justify and possibly unethical to conduct a randomized trial where controls are not tested for penicillin allergy given the amount of evidence justifying its use. 5 Given that a timely PST is not readily available in some hospitals, 24 effective inpatient interventions should strive to incorporate guideline-driven protocols that stratify patients most likely to benefit from PST. 10, 25 However, it is known that the history of penicillin allergy poorly correlates with patients having a positive PST. 19 Thus, allergists should strive to implement the infrastructure and empower other healthcare providers to safely rule out allergy with PST 36 and follow through by updating the patient's allergy on their medical record.
| CONCLUSION
Observation data over the past 20 years have shown inpatient penicillin allergy testing to be a validated, safe, and effective method at ruling out penicillin allergy. The rate of negative tests is comparable to outpatient and perioperative data. A history of penicillin allergy should be seriously questioned and proper evaluation should be undertaken in hospitalized patients who require penicillin-based antibiotics. 5 Further longitudinal studies should address the effect of inpatient penicillin allergy testing in relation to clinical outcomes including length of hospital stay, hospital-acquired infection, readmission rate, and cost related to subsequent healthcare utilization.
Healthcare providers should be empowered to safely perform PST.
This would help risk-stratify patients likely to benefit from early testing and target risk reduction in adverse outcomes related to a documented penicillin allergy.
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